New Search

If you are not happy with the results below please do another search

1 search result for:

1

Spago Nanomedical publishes scientific paper on positive preclinical data with Tumorad® as treatment of solid tumors

Spago Nanomedical AB (publ) today announced the publication of data on the composition, stability, and mode of action for its leading candidate drug 177Lu-SN201. The preclinical results shows that the candidate drug accumulates favorably in tumors, inhibits tumor growth, provides prolonged survival compared to control, and is suitable for systemic treatment of cancer. The paper […]